Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Bausch Health Companies Inc | 64 |
| 2 | Koninklijke Philips NV | 47 |
| 3 | AbbVie Inc | 37 |
| 4 | Insmed Inc | 36 |
| 5 | Johnson and Johnson | 30 |
| 6 | Bayer AG | 24 |
| 7 | aTyr Pharma Inc | 20 |
| 8 | BASF SE | 19 |
| 9 | Government of the United States of America | 19 |
| 10 | Aradigm Corp | 18 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 715 |
| 2 | A61P | Therapeutic activity (drug indications) | 637 |
| 3 | C07D | Heterocyclic compounds | 142 |
| 4 | Y02A | Climate change adaptation | 136 |
| 5 | A61L | Sterilising / disinfecting materials | 102 |
| 6 | C12N | Microorganisms, enzymes | 98 |
| 7 | C07K | Peptides | 90 |
| 8 | A61F | 72 | |
| 9 | A01N | Preservation of bodies; biocides; pest repellents | 68 |
| 10 | C07C | Acyclic and carbocyclic compounds | 54 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| TWO-COMPONENT DIAZON TYPE MATERIAL | 1984 | Sanofi SA | 2 |
| Diamidine compounds as DNA minor groove binders | 2007 | University of North Carolina System | 1 |
| BLACK OF SMOKE THAT HAS REACTED WITH DIAZON SALTS. | 2006 | Cabot Corp | 0 |
| PROCEDURE FOR THE PRODUCTION OF WATER SOLUTIONS OF DIAZON SALTS. | 2003 | Clariant AG | 0 |
| DIAMIDINE COMPOUNDS AS DNA MINOR GROOVE BINDERS | 2002 | University of North Carolina System | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2019 | 3 |
| 2022 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | E. Carboni | 3 | |
| 2 | J. Martínez‐Fernández | 3 | |
| 3 | Matthew D. Hall | National Institutes of Health | 2 |
| 4 | Carleen Klumpp‐Thomas | National Institutes of Health | 2 |
| 5 | Jennifer M. Schomaker | University of Wisconsin–Madison | 2 |
| 6 | Hans‐Joachim Gais | RWTH Aachen University | 2 |
| 7 | Olivia W. Lee | National Institutes of Health | 2 |
| 8 | Rajarshi Guha | National Institutes of Health | 2 |
| 9 | Joy Barnes Cross | The University of Texas Medical Branch at Galveston | 2 |
| 10 | Gerhard Raabe | RWTH Aachen University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Diastereomerically and Enantiomerically Pure 2,3-Disubstituted Pyrrolidines from 2,3-Aziridin-1-ols Using a Sulfoxonium Ylide: A One-Carbon Homologative Relay Ring Expansion | 2007 | 91 | Asymmetric Synthesis and Catalysis |
| Ligand-Controlled Synthesis of Azoles via Ir-Catalyzed Reactions of Sulfoxonium Ylides with 2-Amino Heterocycles | 2016 | 77 | Catalytic C–H Functionalization Methods |
| Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. | 1986 | 67 | Neutrophil, Myeloperoxidase and Oxidative Mechanisms |
| Total Synthesis of Azumamide A and Azumamide E, Evaluation as Histone Deacetylase Inhibitors, and Design of a More Potent Analogue | 2007 | 54 | Catalytic C–H Functionalization Methods |
| SULFOXONE (DIASONE®) SODIUM FOR DERMATITIS HERPETIFORMIS | 1951 | 37 | Celiac Disease Research and Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Sulfoxone Sodium?
Which companies hold the most patents related to Sulfoxone Sodium?
What is the overall patent coverage for this compound?
What are the primary patent classification areas for compounds related to Sulfoxone Sodium?
What notable research has been conducted on sulfoxone-related compounds?